A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Clinical trial NCT06572384 · RECRUITING

Trial details

NCT number: NCT06572384
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2024-09-11
Primary completion: 2028-10-18
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.